Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bangkok Genomics Innovation PCLBKK:BKGI +0.99%45 Days Inventory is 34.96 as of Dec. 2025, which is 4% below its 10-year median of 36.26. GuruFocus rates BKK:BKGI with a GF Score™ of 45/100. The stock has 12 warning signs investors should review. Among 179 Medical Diagnostics & Research companies, Bangkok Genomics Innovation PCL ranks better than 68.72% on this metric.
The historical rank and industry rank for Bangkok Genomics Innovation PCL's Days Inventory or its related term are showing as below:
BKK:BKGI'
s Days Inventory Range Over the Past 10 Years
Min: 22.23 Med: 36.26 Max: 47.42
Current: 41.68
During the past 7 years, Bangkok Genomics Innovation PCL's highest Days Inventory was 47.42. The lowest was 22.23. And the median was 36.26.
BKK:BKGI's Days Inventory is ranked better than 68.72% of 179
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.04
vs BKK:BKGI: 41.68
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bangkok Genomics Innovation PCL's Inventory Turnover for the
three
months ended in Dec. 2025 was 2.61.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bangkok Genomics Innovation PCL's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.22.
Bangkok Genomics Innovation PCL (BKK:BKGI) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Bangkok Genomics Innovation PCL's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bangkok Genomics Innovation PCL's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Bangkok Genomics Innovation PCL Days Inventory Related Terms
Bangkok Genomics Innovation PCL Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Genomics Innovation PCL Days Inventory Chart
BKK:BKGI vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Genomics Innovation PCL Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's Days Inventory distribution charts can be found below:
* The bar in red indicates where Bangkok Genomics Innovation PCL's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Genomics Innovation PCL (BKK:BKGI) has a Days Inventory of 34.96 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bangkok Genomics Innovation PCL and its competitors. This is near median its historical median of 36.26. Over the past decade, Bangkok Genomics Innovation PCL's Days Inventory has ranged from 22.23 to 47.42. According to the industry distribution chart, Bangkok Genomics Innovation PCL ranks #56 out of 179 companies in the Medical Diagnostics & Research industry, placing it in the top 31.3%.
Is Bangkok Genomics Innovation PCL's Days Inventory too high?
Bangkok Genomics Innovation PCL's current Days Inventory of 34.96 is near median its 10-year median of 36.26. Over the past 10 years, this metric has ranged from a low of 22.23 to a high of 47.42. The Medical Diagnostics & Research industry median Days Inventory is 65.04. Bangkok Genomics Innovation PCL's value of 34.96 is 46.2% below this industry median. Based on the distribution chart, Bangkok Genomics Innovation PCL ranks #56 out of 179 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Bangkok Genomics Innovation PCL ranks #56 out of 179 companies for Days Inventory. This puts Bangkok Genomics Innovation PCL in the upper half of its industry. The industry median Days Inventory is 65.04. Bangkok Genomics Innovation PCL's value of 34.96 is 46.2% below this benchmark. Historically, Bangkok Genomics Innovation PCL's own Days Inventory has ranged from 22.23 to 47.42 over the past decade. While the company's 10-year median is 36.26 vs. the industry median of 65.04, Bangkok Genomics Innovation PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 65.04, based on 179 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Genomics Innovation PCL's current Days Inventory of 34.96 is 46.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bangkok Genomics Innovation PCL and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 65.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Genomics Innovation PCL's current Days Inventory is 34.96, which is near median its own 10-year median of 36.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current Days Inventory of 34.96. The current Days Inventory is 34.96, which is near median its 10-year median of 36.26 and 46.2% below the Medical Diagnostics & Research industry median of 65.04. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current Days Inventory is 34.96 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bangkok Genomics Innovation PCL Business Description
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score
Get the complete analysis for BKK:BKGI
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BKGI has been successfully added to your 
